Daclizumab reduces corticosteroid burden in renal transplantation

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1442, 2004-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daclizumab seems to have a renal-sparing effect in patients undergoing liver transplantation

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Sirolimus reduces acute rejection in renal transplantation

Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Ciclosporin reduces risk of diabetes following renal transplantation

Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Corticosteroid Avoidance in Pediatric Renal Transplantation: Can it Be Achieved?

By Jayakumar R. Vidhun Minnie M. Sarwal

Pediatric Drugs, Vol. 6, Iss. 5, 2004-01 ,pp. : 273-287

Adis International

Access to resources Recommend Favorite

Daclizumab + tacrolimus a feasible corticosteroid-free regimen

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite